- Supported exchanges /
- F /
- CY71.F
Anixa Biosciences Inc (CY71 F) stock market data APIs
Anixa Biosciences, Inc., a clinical-stage biotechnology company, focuses on the treatment and prevention of cancer. Its therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR- T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company's vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer " primarily triple negative breast cancer (TNBC), the lethal form of the disease, as well as a vaccine to prevent ovarian cancer. Its vaccine technologies focus on immunizing against retired proteins that found to be expressed in certain forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Anixa Biosciences Inc Financial Data Overview
| 3.18 | |
| 3.18 | |
| - | |
| 3.18 | |
| 3.18 | |
| 2.02-4.66 | |
| 115 M | |
| 32 180 K | |
| 0 | |
| -0.14 | |
| 0.863 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Anixa Biosciences Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA 0
- Earnings Per Share -0.36
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Anixa Biosciences Inc Earnings via APIs
- Latest Release 2021-07-31
- EPS/Forecast -0.08
Get Anixa Biosciences Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
